Stem Cell Treatment For Cardiac Cases

May 8, 2009 - PRLog -- The new findings in stem cell field have stimulated optimism that the progression of heart failure can be prevented or even reversed with cell-based therapy.
Michael reports that his ejection fraction (a measure of the heart’s pumping function) has increased from 41% to 55% after getting stem cell treatment from a Thailand based company. Michael, 81, was very concerned when he was diagnosed with congestive heart failure. He knew he was going downhill.

He was a little apprehensive before his treatment. Michael’s own stem cells were implanted into his coronary arteries via catheter in a simple procedure very similar to an angioplasty.

Eight months later, the stem cell therapy has improved Michael’s quality of life. “I recently visited my doctor - my diagnosis now is that I don’t have heart failure anymore! My ejection fraction is 55%. That is a 30% increase! I’m feeling top shelf. I’m working again. I’m happy.”
In another case, John's mother, “His ejection fraction is near 25% now, but was 10 -15% before he went for treatment in 2005.  A good way to gauge how John is doing is his tolerance for everyday activities, which for him, can be a lot. “I do notice an improvement in that he plays quite physically with his children, can do stairs well and picks up his 15 month old daughter many times a day.” Before the treatment he was having difficulty walking up the stairs.
At 33, John was the youngest person in the patient volunteer list. He had advanced non-ischemic cardiomyopathy and a serious case of atrial fib. Here's what he said approaching the one year mark: “ I was pleased to find out that after 9-10 months I no longer have a-fib”.
“Stem cell treatment is at a nascent stage but we need to understand the life-saving potential of such procedures. Bone-marrow-derived progenitor cells and other progenitor cells can differentiate into vascular cell types, restoring blood flow”, said Karan Goel, an entrepreneur and chairman and founder of Stem Cell Voice of India, which is creating awareness about stem cell treatment.
Heart failure is the leading cause of death worldwide, and current therapies only delay progression of the disease. “Laboratory experiments and recent clinical trials suggest that cell-based therapies can improve cardiac function, and the implications of this for cardiac regeneration are causing great excitement”, Karan said.
“More recently, resident cardiac stem cells have been shown to differentiate into multiple cell types present in the heart, including cardiac muscle cells, indicating that the heart is not terminally differentiated”, he informs.

# # #

Stem Cell Panakea is in the field of regenerative medicine. SCP is a company devoted to the treatment of patients with Stem Cell transplantation therapy